Main

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2023-09-28 03:12:57

expired found date

-

created at

2024-06-08 05:25:46

updated at

2026-01-01 00:41:58

Domain name statistics

length

15

crc

44914

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

122301123

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

58363

mp size raw text

5154

mp inner links count

9

mp inner links status

20 (imported)

Open Graph

title

AstraZeneca - Research-Based BioPharmaceutical Company

description

AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

site name

author

updated

2025-12-20 07:36:42

raw text

AstraZeneca - Research-Based BioPharmaceutical Company Skip to content Skip to navigation Skip to footer Search Menu Search Search Search Close What science can do Stories Publications R&D R&D Our approach Precision medicine Transformative science Data science & AI Clinical innovation Digital health Our technologies Next generation therapeutics R&D strategic centres Our therapy areas All therapy areas Oncology BioPharmaceuticals Cardiovascular, Renal and Metabolism Respiratory & Immunology Vaccines and Immune Therapies Rare Disease Pipeline All medicines Our company Our company Our people Our leadership Cambridge Gothenburg Gaithersburg Careers Careers website Working with us Inclusion and diversity Investors Investor Relations (Global) Investor Relations (Sweden) Resources Governance Shareholder information Dividend policy Key facts FAQs Debt Investors ADR Programme Media ...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Koronawirus (17)

index version

2025110801

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

4088

text words

678

text unique words

362

text lines

162

text sentences

15

text paragraphs

6

text words per sentence

45

text matched phrases

20

text matched dictionaries

6

RSS

rss path

rss status

1 (priority 1 already searched, no matches found)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap path

sitemap status

1 (priority 1 already searched, no matches found)

sitemap review version

1

sitemap urls count

0

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

-

sitemap process date

-

sitemap first import date

-

sitemap last import date

-